Enviva Inc.
EVA · NYSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 2.51 | 0.03 | -1.11 |
| FCF Yield | -495.18% | -8.73% | -7.96% | 0.81% |
| EV / EBITDA | -5.42 | 276.22 | -367.66 | 150.22 |
| Quality | ||||
| ROIC | -26.57% | -4.11% | -5.10% | 4.73% |
| Gross Margin | -13.22% | 15.25% | 7.47% | 12.24% |
| Cash Conversion Ratio | 0.10 | 0.53 | -0.26 | 6.99 |
| Growth | ||||
| Revenue 3-Year CAGR | 4.96% | 7.74% | 15.03% | 15.11% |
| Free Cash Flow Growth | -19.73% | -4.33% | -1,628.35% | 133.49% |
| Safety | ||||
| Net Debt / EBITDA | -5.20 | 90.25 | -99.91 | 43.37 |
| Interest Coverage | -2.79 | -1.20 | -1.72 | 1.34 |
| Efficiency | ||||
| Inventory Turnover | 19.55 | 5.84 | 16.70 | 18.13 |
| Cash Conversion Cycle | 86.36 | 104.44 | 51.06 | 67.60 |